Njoo F L, Stilma J S, van der Lelij A
The Netherlands Ophthalmic Research Institute, Department of Ophthalmo-Immunology, Amsterdam.
Doc Ophthalmol. 1992;79(3):261-7. doi: 10.1007/BF00158256.
A group of 87 onchocerciasis patients from a hyperendemic area without vector control was treated with a single dose of 150 micrograms/kg ivermectin. A second, third and fourth dose was administered 5, 12 and 17 months later to 44, 35 and 25 patients. Skin snip loads reduced substantially following each consecutive dose. However, after three doses 44% of the patients remained skin snip positive. Side-effects decreased from 32.2% requiring medical treatment at the first dose to none after the fourth dose. From this study it was concluded that a complete eradication of microfilariae in skin snips in severely infected persons living in a hyperendemic area without vector control is probably not feasible. Medical supervision for the observation of side-effects after the third dose can be limited.
一组来自没有病媒控制的高度流行地区的87名盘尾丝虫病患者接受了单剂量150微克/千克伊维菌素的治疗。在5、12和17个月后,分别对44名、35名和25名患者给予了第二、第三和第四剂药物。每次连续给药后,皮肤切片中的微丝蚴负荷大幅降低。然而,在三剂给药后,44%的患者皮肤切片仍呈阳性。副作用从第一剂时需要医疗处理的32.2%降至第四剂后的零。从这项研究得出的结论是,对于生活在没有病媒控制的高度流行地区的严重感染者,完全消除皮肤切片中的微丝蚴可能是不可行的。第三剂后观察副作用的医疗监督可以有限。